Furmonertinib 160mg vs 80mg + Chemotherapy in EGFR-Mutated NSCLC With Brain Metastases: Efficacy and Safety Study
Tianjin Medical University Cancer Institute and Hospital
Tianjin Medical University Cancer Institute and Hospital
University of Pittsburgh
St. Jude Children's Research Hospital
University of Kentucky
Sun Yat-sen University
Fundación GECP
Blueprint Medicines Corporation
Sun Yat-sen University
Sun Yat-sen University
Shanghai Pudong Hospital
Sun Yat-sen University
Northwestern University
Northwestern University
UNC Lineberger Comprehensive Cancer Center
Guangzhou Medical University
Shandong Cancer Hospital and Institute